Auf Crowdhouse kann jedermann Anteile an Renditeimmobilen erwerben. Wenige Monate nach dem Start sind über die Plattform Liegenschaften im Wert von 18 Millionen Franken an rund 50 Investoren platziert worden. Die Pipeline ist mit Immobilien gut gefüllt. Und die Pläne für die weitere Entwicklung des Startups sind ambitioniert.
CellSpring, a biotech spin-out from ETH Zurich incorporated in 2015, is evolving quickly. Today Tecan announced a co-marketing agreement to automate CellSpring’s 3D Bloom platform on Tecan’s Freedom EVO workstation.
The swissnex Medtech and Healthcare Startup Tour India from 11-16 September 2016 opens doors to India's medtech ecosystem, connecting startups to key opinion leaders, potential local partners and customers. The swissnex India team will be in Switzerland in June to provide information about the tour and the Indian economy in general.
The Zurich Climate prize honours projects that make a sustainable contribution to climate protection in Switzerland and Liechtenstein. Participating start-ups have the opportunity to win a special start-up award but they can also win prizes in other categories. At the last edition four start-ups had been awarded.
Aleva Neurotherapeutics, a leading company developing next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson’s Disease and Essential Tremor, today announced that it has raised USD 18 million in a Series C financing round. In total, Aleva has raised USD 42 million from renowned private and institutional investors.